TP53 and Alzheimer disease: As the unfolded p53 conformation is induced by the pro-oxidant environment [59], it has the potential to be one of these oxidative stress markers that can be used for therapeutic monitoring in studies evaluating the impact of antioxidant therapies on the disease progression of AD.